Efficacy

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

by

Scientists harnessed AI to create mutation-resistant antibodies that outperformed conventional drug design, offering a powerful new tool against fast-evolving viruses like SARS-CoV-2. Study: AI designed, mutation resistant broad neutralizing antibodies against multiple SARS-CoV-2 strains. Image Credit: Lightspring / Shutterstock In a recent study in the journal Scientific Reports, researchers tested and leveraged several cutting-edge technologies, including machine … Read more

Diabetes drugs GLP-1RA and SGLT2i lower dementia risk in older adults, study finds

by

A new study links two widely prescribed diabetes drugs to a 33–43% lower risk of Alzheimer’s and related dementias, offering hope for repurposing existing treatments to tackle one of aging’s most devastating diseases. Study: GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias. Image Credit: PeopleImages.com – Yuri A / Shutterstock.com … Read more

Vaccine trial shows promise for saving California condors from bird flu

by

In a high-stakes trial prompted by a deadly outbreak, researchers tested a poultry flu vaccine in condors and found promising immune responses, offering a new lifeline for one of North America’s rarest birds. Image Credit: Amy Osier / Shutterstock A team of US-based researchers recently tested the safety and efficacy of a licensed avian influenza vaccine in … Read more

Hydroxyurea shows long-term benefits for children with sickle cell disease

by

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood Advances. “This is one of the first large, real-world, long-term studies to assess the efficacy of hydroxyurea outside of a controlled setting,” said study author Paul George, MD, … Read more

What really causes keto flu, and how can you prevent it?

by

As ketogenic diets grow in popularity, a new review sheds light on the short-term side effects of keto-induction and offers science-backed solutions to help manage the dreaded “keto flu.” Symptoms during initiation of a ketogenic diet: a scoping review of occurrence rates, mechanisms and relief strategies. Image Credit: eldar nurkovic / Shutterstock In a recent study published … Read more

Coaxial silicone drains reduce pain after VATS lobectomy without compromising efficacy

by

Apr 10 2025 Background: Chest drains are routinely used after video-assisted thoracoscopic surgery (VATS) lung resections to evacuate fluid and air from the pleural space. We compared the impact of coaxial silicone (SIL) drains vs. standard polyvinyl chloride (PVC) drains on postoperative pain, drainage efficacy, and short-term treatment outcome following VATS lobectomy. Methods: The prospective … Read more

Fecal microbiota transplantation emerges as a promising approach to H. pylori eradication

by

Helicobacter pylori (H. pylori) is a widespread bacterial infection associated with gastritis, peptic ulcers, and gastric cancer. While conventional antibiotic-based treatments have been the gold standard for eradication, their efficacy has been steadily declining due to the alarming rise in antibiotic resistance. This has spurred interest in alternative therapies, one of which is fecal microbiota transplantation … Read more

Quinoline Antiviral: Promising SARS-CoV-2 Treatment

by

New hope for COVID-19 Treatment: Novel Antiviral Compound Shows Promise Table of Contents New hope for COVID-19 Treatment: Novel Antiviral Compound Shows Promise The Quest for Innovative SARS-cov-2… The post Quinoline Antiviral: Promising SARS-CoV-2 Treatment appeared first on NewsyList. Source link

LBNPs: Revolutionizing cancer therapy

by

Announcing a new article publication for the BIO Integration journal. Lipid-based Nanoparticles (LBNPs) have emerged as a transformative approach in cancer treatment, offering innovative drug delivery solutions that enhance therapeutic efficacy while minimizing adverse effects. This study highlights how LBNPs have been used to overcome the limitations of traditional chemotherapy and improve patient outcomes by exploring … Read more

IL-12 cytokine factory demonstrates success in targeting hard-to-treat cancers

by

 A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable “cytokine factory” that safely triggers potent immune responses against hard-to-treat cancers, including metastatic melanoma, pancreatic and colorectal tumors. The study, published in The Journal of ImmunoTherapy of Cancer, details how an immunoprotected device near the tumor microenvironment containing cells … Read more